Corvex Management’s Biogen BIIB Stock Holding History

Corvex Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-52,000	Closed	-$16.3M	–	41
2016 Q3	$16.3M	Buy	+52,000	New	+$15.4M	0.3%	26

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Corvex Management's BIIB Position: Q4 2016 in Review

Corvex Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 52,000 shares — an estimated $16.3M sold.

Corvex Management first reported a position in BIIB in Q3 2016 and held it in 1 quarter. The position peaked at $16.3M in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

Corvex Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
Corvex Management sold 52,000 Biogen shares in Q4 2016, an estimated $16.3M.
Corvex Management first reported a position in Biogen in Q3 2016 and held it in 1 quarter.
Corvex Management's Biogen position peaked at $16.3M in Q3 2016.
1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Corvex Management's 13F filing for Q4 2016, filed 14 Feb 2017.